Managed Healthcare Executive November 6, 2023
Precision medicine will lead to fewer cases of ocular cancers, earlier diagnosis, and more targeted and sight-saving treatments.
Ocular cancers will one day have cures, and the key lies with liquid biopsies, Daniel S. Gombos, M.D., said during a session at the annual meeting of the American Academy of Ophthalmology.
Concepts like liquid biopsy — an assessment of circulating biomarkers in the blood — and precision medicine weren’t even conceivable 30 years ago. But now liquid biopsy has become important in oncology for identifying treatments and monitoring response to therapy and disease progression in lung, breast, prostate, colorectal, ovarian, and other solid cancers.
Eye cancers, although rare, have no early symptoms and may be hard to detect. The American Cancer...
Today's Sponsors
Today's Sponsor